Osama A. Raslan MD, MBBCh, Presenter: Nothing to Disclose

Medhat M. Osman MD, Abstract Co-Author: Speaker, Koninklijke Philips NV

Vilaas Shetty MD, Abstract Co-Author: Nothing to Disclose

Talha S. Allam MD, Abstract Co-Author: Nothing to Disclose

1. To understand the PET/CT cranial nerve (CN) cross sectional anatomy. 2. When to suspect and how to diagnose CN pathology on FDG-PET/CT using the primary signs of CN involvement (e.g. widening of the exit foramen), and secondary signs (e.g. hypometabolic denervated atrophic muscle). 3. Recognize the importance of perineural spread along the CNs in assessing PET/CT scan in all patients with head and neck cancer.  

• Introduction about the implication of detecting CN pathology on patient management. • Description of clinical scenarios that should prompt a search for cranial nerve pathology. • Description of the PET/CT anatomy, as well as the primary and secondary signs of involvement of each of the 12th CNs. The following CNs pathology are presented with illustration: CN I, II, V2, V3, VI, VII, VIII, X and XI.  

http://abstract.rsna.org/uploads/2014/14011877/14011877_1w96.pdf

Raslan, O, Osman, M, Shetty, V, Allam, T, (18) F-FDG-PET/CT of Cranial Nerve Pathology.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14011877.html